These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11485409)

  • 1. HIV-1 NL4-3, but not IIIB, inhibits JAK3/STAT5 activation in CD4(+) T cells.
    Selliah N; Finkel TH
    Virology; 2001 Aug; 286(2):412-21. PubMed ID: 11485409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutting edge: JAK3 activation and rescue of T cells from HIV gp120-induced unresponsiveness.
    Selliah N; Finkel TH
    J Immunol; 1998 Jun; 160(12):5697-701. PubMed ID: 9637477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).
    Nielsen M; Svejgaard A; Röpke C; Nordahl M; Odum N
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10995-9. PubMed ID: 7479924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
    Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional uncoupling of the Janus kinase 3-Stat5 pathway in malignant growth of human T cell leukemia virus type 1-transformed human T cells.
    Kirken RA; Erwin RA; Wang L; Wang Y; Rui H; Farrar WL
    J Immunol; 2000 Nov; 165(9):5097-104. PubMed ID: 11046040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in phosphorylation of the IL-2R associated JAK/STAT proteins between HTLV-I(+), IL-2-independent and IL-2-dependent cell lines and uncultured leukemic cells from patients with adult T-cell lymphoma/leukemia.
    Zhang Q; Lee B; Korecka M; Li G; Weyland C; Eck S; Gessain A; Arima N; Lessin SR; Shaw LM; Luger S; Kamoun M; Wasik MA
    Leuk Res; 1999 Apr; 23(4):373-84. PubMed ID: 10229324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell receptor-induced calcineurin activation regulates T helper type 2 cell development by modifying the interleukin 4 receptor signaling complex.
    Yamashita M; Katsumata M; Iwashima M; Kimura M; Shimizu C; Kamata T; Shin T; Seki N; Suzuki S; Taniguchi M; Nakayama T
    J Exp Med; 2000 Jun; 191(11):1869-79. PubMed ID: 10839803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH; Kirken RA; Erwin RA; Yu CR; Farrar WL
    J Immunol; 1999 Apr; 162(7):3897-904. PubMed ID: 10201908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular role of TGF-beta, secreted from a new type of CD4+ suppressor T cell, NY4.2, in the prevention of autoimmune IDDM in NOD mice.
    Han HS; Jun HS; Utsugi T; Yoon JW
    J Autoimmun; 1997 Jun; 10(3):299-307. PubMed ID: 9218758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligation of RARgamma inhibits proliferation of phytohaemagglutinin-stimulated T-cells via down-regulating JAK3 protein levels.
    Ludányi K; Nagy ZS; Alexa M; Reichert U; Michel S; Fésüs L; Szondy Z
    Immunol Lett; 2005 Apr; 98(1):103-13. PubMed ID: 15790515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of proliferation and phosphorylation of Jak3 and STAT5 in malignant T-cell lymphoma cells by derivatives of octylamino-undecyl-dimethylxanthine.
    Wasik MA; Nowak I; Zhang Q; Shaw LM
    Leuk Lymphoma; 1998 Feb; 28(5-6):551-60. PubMed ID: 9613985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-modulation of IL-2-triggered JAK3-STAT5 signaling following CD4-ligand binding.
    Lowry RP; Goebel J
    Transplant Proc; 1999; 31(1-2):820-1. PubMed ID: 10083356
    [No Abstract]   [Full Text] [Related]  

  • 13. IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common gamma-chain of the IL-2 receptor.
    Grundström S; Dohlsten M; Sundstedt A
    J Immunol; 2000 Feb; 164(3):1175-84. PubMed ID: 10640728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of early T-cell-receptor-triggered cellular activation by the Janus kinase 3 inhibitor WHI-P-154.
    Säemann MD; Zeyda M; Diakos C; Szekeres A; Böhmig GA; Kelemen P; Parolini O; Stockinger H; Prieschl EE; Stulnig TM; Baumruker T; Zlabinger GJ
    Transplantation; 2003 Jun; 75(11):1864-72. PubMed ID: 12811247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of interleukin 2 signaling and signal transducer and activator of transcription (STAT)5 activation during T cell receptor-mediated feedback inhibition of T cell expansion.
    Lee IH; Li WP; Hisert KB; Ivashkiv LB
    J Exp Med; 1999 Nov; 190(9):1263-74. PubMed ID: 10544198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus-1 envelope glycoproteins and anti-CD4 antibodies inhibit interleukin-2-induced Jak/STAT signalling in human CD4 T lymphocytes.
    Kryworuchko M; Pasquier V; Thèze J
    Clin Exp Immunol; 2003 Mar; 131(3):422-7. PubMed ID: 12605694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3/STAT5 signaling pathway.
    Bingisser RM; Tilbrook PA; Holt PG; Kees UR
    J Immunol; 1998 Jun; 160(12):5729-34. PubMed ID: 9637481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 down-regulates CD4 costimulation of TCR/CD3-directed tyrosine phosphorylation through CD4/p56lck dissociation.
    Kanner SB; Haffar OK
    J Immunol; 1995 Mar; 154(6):2996-3005. PubMed ID: 7876562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of interleukin-2 unresponsiveness and down-regulation of the JAK-STAT system upon activation through the T cell receptor.
    Miyatake S; Sakuma M; Saito T
    Eur J Immunol; 1997 Jul; 27(7):1816-23. PubMed ID: 9247597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective interleukin-2-dependent STAT5 signalling in CD8 T lymphocytes from HIV-positive patients: restoration by antiretroviral therapy.
    Kryworuchko M; Pasquier V; Keller H; David D; Goujard C; Gilquin J; Viard JP; Joussemet M; Delfraissy JF; Thèze J
    AIDS; 2004 Feb; 18(3):421-6. PubMed ID: 15090793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.